StockData
GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Glucose Health, Inc.

Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026

Market cap
$1.82M
P/E (TTM)
–
Dividend yield
–

Glucose Health, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Glucose Health does not break out revenue by segment, region or product in the tagged data of its filings for this period type.